FDA again misses a user fee review action decision in the wake of mass staff cuts, the third miss in a month this time it's a GSK Nucala sNDA for tre...
Speakers at the DTC National conference suggest a ban on drug DTC ads is not very likely.
Former FDA commissioners Scott Gottlieb and Mark McClellan voice concerns about an HHS proposed reorganization of FDA that would centralize the review...
The FDA Office of Inspections and Investigations ombudsman program calls for establishing a dedicated Web page as a stakeholder education hub.
FDA approves an Orchestra BioMed IDE to begin a pivotal clinical trial evaluating its next generation Virtue Sirolimus-AngioInfusion Balloon for treat...
FDA grants Italfarmaco a fast track designation to givinostat for treating patients with polycythemia vera, a rare hematologic cancer.
FDA commissioner Michael Makary says the agency is rolling out a generative AI-assisted scientific review tool to all Centers by 6/30.
A northern Texas judge rules in FDAs favor in a case challenging its decision last year to remove Eli Lillys weight loss and diabetes drugs Zepbound a...